Literature DB >> 25319733

Adaptive graph-based multiple testing procedures.

Florian Klinglmueller1, Martin Posch, Franz Koenig.   

Abstract

Multiple testing procedures defined by directed, weighted graphs have recently been proposed as an intuitive visual tool for constructing multiple testing strategies that reflect the often complex contextual relations between hypotheses in clinical trials. Many well-known sequentially rejective tests, such as (parallel) gatekeeping tests or hierarchical testing procedures are special cases of the graph based tests. We generalize these graph-based multiple testing procedures to adaptive trial designs with an interim analysis. These designs permit mid-trial design modifications based on unblinded interim data as well as external information, while providing strong family wise error rate control. To maintain the familywise error rate, it is not required to prespecify the adaption rule in detail. Because the adaptive test does not require knowledge of the multivariate distribution of test statistics, it is applicable in a wide range of scenarios including trials with multiple treatment comparisons, endpoints or subgroups, or combinations thereof. Examples of adaptations are dropping of treatment arms, selection of subpopulations, and sample size reassessment. If, in the interim analysis, it is decided to continue the trial as planned, the adaptive test reduces to the originally planned multiple testing procedure. Only if adaptations are actually implemented, an adjusted test needs to be applied. The procedure is illustrated with a case study and its operating characteristics are investigated by simulations.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  adaptive design; graphical approach; multiple comparisons; multiple endpoints; partial conditional error rate; treatment selection

Mesh:

Year:  2014        PMID: 25319733      PMCID: PMC4789493          DOI: 10.1002/pst.1640

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  37 in total

1.  Multiple comparisons to both a negative and a positive control.

Authors:  Mario Hasler
Journal:  Pharm Stat       Date:  2012-01-10       Impact factor: 1.894

2.  An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints.

Authors:  Martin Jenkins; Andrew Stone; Christopher Jennison
Journal:  Pharm Stat       Date:  2010-12-08       Impact factor: 1.894

3.  An evaluation of methods for testing hypotheses relating to two endpoints in a single clinical trial.

Authors:  Ting-Li Su; Ekkehard Glimm; John Whitehead; Mike Branson
Journal:  Pharm Stat       Date:  2012-02-15       Impact factor: 1.894

4.  Adaptive designs for single-arm phase II trials in oncology.

Authors:  Stefan Englert; Meinhard Kieser
Journal:  Pharm Stat       Date:  2012-03-12       Impact factor: 1.894

5.  Testing non-inferiority and superiority for two endpoints for several treatments with a control.

Authors:  John Lawrence
Journal:  Pharm Stat       Date:  2010-10-15       Impact factor: 1.894

6.  The reassessment of trial perspectives from interim data--a critical view.

Authors:  Peter Bauer; Franz Koenig
Journal:  Stat Med       Date:  2006-01-15       Impact factor: 2.373

7.  The fallback procedure for evaluating a single family of hypotheses.

Authors:  Brian L Wiens; Alexei Dmitrienko
Journal:  J Biopharm Stat       Date:  2005       Impact factor: 1.051

8.  Testing and estimation in flexible group sequential designs with adaptive treatment selection.

Authors:  Martin Posch; Franz Koenig; Michael Branson; Werner Brannath; Cornelia Dunger-Baldauf; Peter Bauer
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

9.  A graphical approach to sequentially rejective multiple test procedures.

Authors:  Frank Bretz; Willi Maurer; Werner Brannath; Martin Posch
Journal:  Stat Med       Date:  2009-02-15       Impact factor: 2.373

10.  Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology.

Authors:  Werner Brannath; Emmanuel Zuber; Michael Branson; Frank Bretz; Paul Gallo; Martin Posch; Amy Racine-Poon
Journal:  Stat Med       Date:  2009-05-01       Impact factor: 2.373

View more
  3 in total

1.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

2.  A simple and flexible graphical approach for adaptive group-sequential clinical trials.

Authors:  Toshifumi Sugitani; Frank Bretz; Willi Maurer
Journal:  J Biopharm Stat       Date:  2014-11-05       Impact factor: 1.051

Review 3.  Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Authors:  Ralf-Dieter Hilgers; Malgorzata Bogdan; Carl-Fredrik Burman; Holger Dette; Mats Karlsson; Franz König; Christoph Male; France Mentré; Geert Molenberghs; Stephen Senn
Journal:  Orphanet J Rare Dis       Date:  2018-05-11       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.